OpenDBM

AiCure is an AI and advanced data analytics company that monitors patient behavior and enables remote patient engagement in clinical trials. AiCure improves predictability of study timelines, reduces costs and accelerates timelines through remote patient engagement and assessments, including measuring digital biomarkers and real-time monitoring of patient dosing. Founded in 2010 and funded by the National Institutes of Health (NIH) and leading institutional investors, AiCure has more than 65 issued patents and works with global clients in over 30 countries. AiCure is globally recognized and is a recipient of the Scrip Award, AI 100 and Digital Health 150. For more information, please visit www.aicure.com. 

New Leaf Venture Partners

Palisades Growth

Biomatics Capital Partners

Pritzker Group Venture Capital

Singtel Innov8

SpringRock Ventures

Tribeca Venture Partners

Accelmed

Silicon Valley Bank

Asahi Kasei

AiCure

Today is the start of #OCTWestCoast. Make sure to stop by booth #83 and visit with Sondra Pepe and Amy J Ford, MA ORGL from AiCure to learn how our smartphone-based AI platform leverages predictive analytics to manage risk in your clinical research.

The 16th Annual Outsourcing in Clinical Trials West Coast is a collaborative environment where pharma & biotech leaders can find solutions to current challenges through innovations and partnerships.

#digitalinnovation 

The 15th Annual #SCOPESummit is this Sunday, February 11th in Orlando, Florida. AiCure will be attending and we look forward to connecting with you.

The Scope Summit aims to drive innovation in clinical trials and digital health.  Execution of this vital work requires collaboration, innovation, and strategic decision-making.

Please connect with one of our team members to learn more about how AiCure uses a smartphone-based AI platform to support Medication Adherence and Dosing Support and gain novel patient insights in clinical trials.

Joshua Wilson
Amanda Paley
Greg Zak

Learn more about Scope Summit: https://lnkd.in/g9N7SgA

#SCOPE2024 #clinicaltrials 

Join AiCure at booth 83 during #OCTWestCoast, taking place on February 6-7, 2024, in Burlingame, California. 

Our team will showcase how our Artificial Intelligence smartphone-based platform supports Medication Adherence and Dosing Support, providing novel patient insights. 

Connect with Sondra Pepe and Amy J Ford, MA ORGL to schedule a meeting and learn more. 

For additional details about OCT West Coast, visit the event's official website: https://lnkd.in/guBVpr77

#clincaltrials

AiCure has announced new funding, new patents awarded, and new members of the leadership team. 

"AiCure's innovative software and technology are designed to improve patient engagement and sponsor insights in clinical trials, making it a valuable player in the life sciences industry. With its continued growth and focus on innovation, AiCure is poised to make a lasting impact on the future of clinical research."

Read the full press release: https://lnkd.in/eyBSZ9yT

#growth #clinicalresearch 

"Research into substance use disorder treatments is complex and evolving, uniquely shaped by scientific advancements, societal attitudes, and the changing nature of substance use disorders themselves."

AiCure's latest blog covers how our smartphone-based platform was used in a Substance Use Disorder (SUD) trial to improve treatment adherence and collect daily reports on drug and alcohol use. This approach offers several advantages over traditional methods, making it a powerful tool for SUD clinical trial teams.

Read the full blog here: https://lnkd.in/d92dEARE

#ClinicalTrials #MedicationAdherence #HealthcareInnovation #substanceusedisorder 

AiCure is a patient-centric eClinical trials management platform company that empowers life science and healthcare organizations to unlock valuable unbiased, computer-vision driven insights to optimize personalized care.

COM:AICURE

AiCure

Filings Not Available